ArticleStem cell research & therapy2022
Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy.
Dagmara Grot et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it